MRK [merck & company ] bullishUS STOCK merk&company is in demand zone .its time to take long
drawn on liquidity = 97 $
target 97 $
Long
Merck & Co., Inc.
No trades
No trades
Compare with Merck & Co., Inc.
1.10 EUR
15.54 B EUR
55.28 B EUR
2.46 B
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Company info
Sector
Industry
CEO
Robert M. Davis
Website
Headquarters
Rahway
Founded
1891
IPO date
Jan 1, 1941
ISIN
US58933Y1055
CUSIP
58933Y105
FIGI
BBG01BBXFC79
Identifiers
ISIN US58933Y1055
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Long
Merck Significant Upside on the cardsMerck has made a Kiss of Love in True Strength Indicator 1Day Chart. 1Day Fisher Transform has made a Double Bottom. 1W Fisher is already up.
A significant rise is on the cards. It has also come out of TRIANGLE pattern at Bottom.
A Buy at current level.
Target - 1Day Fisher Top (Few weeks).
Long
Merck & Company: Channel Breakout & Target is 0.6 Fib, +13% ROIIn Merck & Company, a Rising Channel Pattern has formed, and the Trendline has Breakout below. The Target is the 0.5 or 0.6 Fibonacci Retracement levels, with the Potential to Achieve a +13% Profit.
Short
MRK Price Action Trading AnalysisConfirmation for this Short Entry:-
1: Market Taking Rejection from Supply Area
2: forming Triangle pattern and Market taking pullback from upper trend line
Short
Short
See all ideas
Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Maturity dateDec 4, 2065
Coupon5.70% (Fixed)
Maturity dateSep 15, 2042
Coupon3.60% (Fixed)
Maturity dateMay 17, 2063
Coupon5.15% (Fixed)
Maturity dateMay 17, 2053
Coupon5.00% (Fixed)
Maturity dateMay 22, 2056
Coupon5.85% (Fixed)
Maturity dateDec 4, 2055
Coupon5.55% (Fixed)
Maturity dateDec 10, 2061
Coupon2.90% (Fixed)
Maturity dateSep 15, 2055
Coupon5.70% (Fixed)
Maturity dateMar 7, 2049
Coupon4.00% (Fixed)
Maturity dateJun 24, 2050
Coupon2.45% (Fixed)
Maturity dateMay 22, 2046
Coupon5.75% (Fixed)
See all 6MK bonds
Frequently asked questions
The current price of 6MK is 134.54 EUR — it has increased by 3.24% in the past 24 hours. Watch Merck & Co., Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSESOF exchange Merck & Co., Inc. stocks are traded under the ticker 6MK.
6MK stock has risen by 6.41% compared to the previous week, the month change is a 8.94% rise, over the last year Merck & Co., Inc. has showed a 85.57% increase.
We've gathered analysts' opinions on Merck & Co., Inc. future price: according to them, 6MK price has a max estimate of 166.71 EUR and a min estimate of 94.11 EUR. Watch 6MK chart and read a more detailed Merck & Co., Inc. stock forecast: see what analysts think of Merck & Co., Inc. and suggest that you do with its stocks.
6MK stock is 3.14% volatile and has beta coefficient of −0.34. Track Merck & Co., Inc. stock price on the chart and check out the list of the most volatile stocks — is Merck & Co., Inc. there?
Today Merck & Co., Inc. has the market capitalization of 324.03 B, it has decreased by −1.71% over the last week.
Yes, you can track Merck & Co., Inc. financials in yearly and quarterly reports right on TradingView.
Merck & Co., Inc. is going to release the next earnings report on Oct 29, 2026. Keep track of upcoming events with our Earnings Calendar.
6MK earnings for the last quarter are −0.11 EUR per share, whereas the estimation was −0.24 EUR resulting in a 51.94% surprise. The estimated earnings for the next quarter are 1.85 EUR per share. See more details about Merck & Co., Inc. earnings.
Merck & Co., Inc. revenue for the last quarter amounts to 14.54 B EUR, despite the estimated figure of 14.33 B EUR. In the next quarter, revenue is expected to reach 15.26 B EUR.
6MK net income for the last quarter is −1.17 B EUR, while the quarter before that showed −3.67 B EUR of net income which accounts for 0.00% change. Track more Merck & Co., Inc. financial stats to get the full picture.
Yes, 6MK dividends are paid quarterly. The last dividend per share was 0.74 EUR. As of today, Dividend Yield (TTM)% is 2.31%. Tracking Merck & Co., Inc. dividends might help you take more informed decisions.
Merck & Co., Inc. dividend yield was 3.12% in 2025, and payout ratio reached 45.05%. The year before the numbers were 3.14% and 46.32% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 16, 2026, the company has 75 K employees. See our rating of the largest employees — is Merck & Co., Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Merck & Co., Inc. EBITDA is 16.65 B EUR, and current EBITDA margin is 45.17%. See more stats in Merck & Co., Inc. financial statements.
Like other stocks, 6MK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Merck & Co., Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Merck & Co., Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Merck & Co., Inc. stock shows the buy signal. See more of Merck & Co., Inc. technicals for a more comprehensive analysis.